Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Biomedical Physics & Engineering Express
|
January 28, 2026
Sequential glioblastoma segmentation via Topological Data Analysis and spatial adjacency
Jihun Bae, Hunmin Lee, Jinglu Hu
Biomedical Physics & Engineering Express
|
December 20, 2024
HeatGSNs: Integrating Eigenfilters and Low-Pass Graph Heat Kernels into Graph Spectral Convolutional Networks for Brain Tumor Segmentation and Classification
Jihun Bae, Hunmin Lee, Jinglu Hu
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 10, 2019
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
Sang-Heon Cho, Seunghoon Han, Jong-Lyul Ghim, et al.
Expert Opinion on Biological Therapy
|
June 21, 2024
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, et al.
Expert Opinion on Investigational Drugs
|
May 26, 2023
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, single-dose phase I study
Kyung-Sang Yu, Byungwook Kim, Dongseong Shin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Biomedical Physics & Engineering Express
|
January 28, 2026
Sequential glioblastoma segmentation via Topological Data Analysis and spatial adjacency
Jihun Bae, Hunmin Lee, Jinglu Hu
Biomedical Physics & Engineering Express
|
December 20, 2024
HeatGSNs: Integrating Eigenfilters and Low-Pass Graph Heat Kernels into Graph Spectral Convolutional Networks for Brain Tumor Segmentation and Classification
Jihun Bae, Hunmin Lee, Jinglu Hu
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 10, 2019
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
Sang-Heon Cho, Seunghoon Han, Jong-Lyul Ghim, et al.
Expert Opinion on Biological Therapy
|
June 21, 2024
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, et al.
Expert Opinion on Investigational Drugs
|
May 26, 2023
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, single-dose phase I study
Kyung-Sang Yu, Byungwook Kim, Dongseong Shin, et al.
Page
of 1